News | November 14, 2011

GE Submits First Module of FDA Application for Breast Tomosynthesis System

November 14, 2011 — GE Healthcare announced it recently submitted to the U.S. Food and Drug Administration (FDA) the first module of its premarket approval application (PMA) for GE Breast Tomosynthesis. The module is an option of the Senographe Essential system. 

In this first PMA module, the company has provided the FDA with the device description and non-clinical information, including phantom testing and detector performance evaluation. The option will acquire multiple projection views to produce 3-D digital breast tomosynthesis (DBT) images intended to be suitable for screening and diagnosis of breast cancer. More than 1,200 Senographe Essentials are in clinical use in the United States today.

Earlier this summer, the company received FDA agreement to proceed with a PMA modular submission consistent with the application shell proposed by GE. The modular review approach allows applicants to submit preclinical data and manufacturing information for FDA review while they continue to collect, compile, and analyze clinical data for the submission. In short, a modular PMA is a compilation of sections or "modules" submitted at different times that together become a complete premarket approval application.

The modular approach increases the likelihood an applicant will be able to resolve deficiencies identified by FDA earlier in the review process than would occur with a traditional PMA application. GE intends to file the remaining three modules of its DBT PMA with the FDA over the coming year.

For more information:

Related Content

Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)... Launches European-Focused Education Coalition
News | Breast Density | February 19, 2018 (DB-I) announced plans for international expansion with specialized content for Europe and...
Microbubbles Make Breast Cancer More Susceptible to Radiation Therapy
News | Women's Health | February 01, 2018
February 1, 2018 – Injecting breast cancer with oxygen-filled microbubbles makes tumors three-times more sensitive to
An example of opto-acoustic breast imaging using the Seno system.

An example of opto-acoustic breast imaging using the Seno system.  

Feature | RSNA 2017 | January 29, 2018
January 26, 2017 — There were three high-impact clinical trials presented at the 2017 Radiological Society of North A
What It Takes to Remain an MQSA-Qualified Inspector
Feature | Mammography | January 26, 2018
The U.S. Food and Drug Administration (FDA) published a new Insight Article detailing the oversight process for the...
Transpara Deep Learning Software Matches Experienced Radiologists in Mammogram Reading
News | Computer-Aided Detection Software | January 12, 2018
Deep learning and artificial intelligence improves the efficiency and accuracy of reading mammograms, according to...
Fat Distribution in Women and Men Provides Clues to Heart Attack Risk
News | Women's Health | January 11, 2018
January 11, 2018 – It’s not the amount of fat in your body but where it is stored that may increase your risk for hea
Women Prefer Getting Mammograms Every Year
News | Mammography | January 09, 2018
Women prefer to get their mammograms every year, instead of every two years, according to a new study presented at the...
Overlay Init